Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Current Leases: 2019-2025

Historic Current Leases for AC Immune (ACIU) over the last 7 years, with Sep 2025 value amounting to $1.3 million.

  • AC Immune's Current Leases rose 63.08% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 63.08%. This contributed to the annual value of $1.3 million for FY2025, which is N/A change from last year.
  • Per AC Immune's latest filing, its Current Leases stood at $1.3 million for Q3 2025, which was up 4.09% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Current Leases registered a high of $628.4 million during Q3 2021, and its lowest value of $1,171 during Q4 2024.
  • Its 3-year average for Current Leases is $785,339, with a median of $759,680 in 2024.
  • Per our database at Business Quant, AC Immune's Current Leases skyrocketed by 137,655.90% in 2021 and then plummeted by 99.90% in 2022.
  • Quarterly analysis of 5 years shows AC Immune's Current Leases stood at $618,166 in 2021, then fell by 7.98% to $568,836 in 2022, then soared by 33.18% to $757,582 in 2023, then crashed by 99.85% to $1,171 in 2024, then surged by 63.08% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.3 million for Q2 2025, and $1.1 million during Q1 2025.